Cooperative control of tumor suppressor genes by a network of oncogenic microRNAs

Cell Cycle

Volumn 10, Issue 17, 2011, Pages 2845-2849

  Mavrakis, Konstantinos J ^a   Leslie, Christina S ^a   Wendel, Hans Guido ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

microRNA; T cell leukemia; Targets

Indexed keywords

MICRORNA;

GENE CONTROL; GENE EXPRESSION; GENE MUTATION; GENETIC SCREENING; HUMAN; LEUKEMOGENESIS; REVIEW; T CELL LEUKEMIA; TUMOR SUPPRESSOR GENE;

EID: 80052399992     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.10.17.16959     Document Type: Review

References (41)

1. Mavrakis K.J., Van Der Meulen J., Wolfe A.L., Liu X., Mets E., Taghon T., et al. A cooperative microRNA- tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL). Nat Genet 2011; 43:673-8; PMID:21642990; DOI:10.1038/ng.858.
2. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism and function. Cell 2004; 116:281- 97; PMID:14744438; DOI:10.1016/S0092- 8674(04)00045-5.
3. Herrera-Merchan A., Cerrato C., Luengo G., Dominguez O., Piris M.A., Serrano M., et al. miR- 33-mediated downregulation of p53 controls hematopoietic stem cell self-renewal. Cell Cycle 2010; 9:3277-85; PMID:20703086; DOI:10.4161/ cc.9.16.12598.
4. Merkel O., Asslaber D., Pinon J.D., Egle A., Greil R. Interdependent regulation of p53 and miR- 34a in chronic lymphocytic leukemia. Cell Cycle 2010; 9:2764-8; PMID:20581456; DOI:10.4161/ cc.9.14.12267.
5. Noonan E.J., Place R.F., Basak S., Pookot D., Li L.C. miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells. Oncotarget 2010; 1:349-358; PMID:20948989.
6. Smits M., Nilsson J., Mir S.E., Van der Stoop P.M., Hulleman E., Niers J.M., et al. miR-101 is downregulated in glioblastoma resulting in EZH2-induced proliferation, migration and angiogenesis. Oncotarget 2010; 1:710-720; PMID:21321380.
7. Tam W., Ben-Yehuda D., Hayward W.S. bic, a novel gene activated by proviral insertions in avian leukosis virus-induced lymphomas, is likely to function through its noncoding RNA. Mol Cell Biol 1997; 17:1490-1502; PMID:9032277.
8. Eis P.S., Tam W., Sun L., Chadburn A., Li Z., Gomez M.F., et al. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci USA 2005; 102:3627-32; PMID:15738415; DOI:10.1073/ pnas.0500613102.
9. Tam W., Hughes S.H., Hayward W.S., Besmer P. Avian bic, a gene isolated from a common retroviral site in avian leukosis virus-induced lymphomas that encodes a noncoding RNA, cooperates with c-myc in lymphomagenesis and erythroleukemogenesis. J Virol 2002; 76:4275-86; PMID:11932393; DOI:10.1128/ JVI.76.9.4275-86.2002.
10. Sonoki T., Iwanaga E., Mitsuya H., Asou N. Insertion of microRNA-125b-1, a human homologue of lin-4, into a rearranged immunoglobulin heavy chain gene locus in a patient with precursor B-cell acute lymphoblastic leukemia. Leukemia 2005; 19:2009-10; PMID:16151463; DOI:10.1038/sj.leu.2403938.
11. Bousquet M., Harris M.H., Zhou B., Lodish HF. MicroRNA miR-125b causes leukemia. Proc Natl Acad Sci USA 2010; 107:21558-63; PMID:21118985; DOI:10.1073/pnas.1016611107.
12. He L., Thomson J.M., Hemann MT, Hernando- Monge E, Mu D, Goodson S, et al. A microRNA polycistron as a potential human oncogene. Nature 2005; 435:828-33; PMID:15944707; DOI:10.1038/ nature03552.
13. Xiao C., Srinivasan L., Calado D.P., Patterson H.C., Zhang B., Wang J., et al. Lymphoproliferative disease and autoimmunity in mice with increased miR-17- 92 expression in lymphocytes. Nat Immunol 2008; 9:405-14; PMID:18327259; DOI:10.1038/ni1575.
14. Mendell JT. miRiad roles for the miR-17-92 cluster in development and disease. Cell 2008; 133:217-22; PMID:18423194; DOI:10.1016/j.cell.2008.04.001.
15. Calin G.A., Dumitru C.D., Shimizu M., Bichi R., Zupo S., Noch E., et al. Frequent deletions and downregulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002; 99:15524-9; PMID:12434020; DOI:10.1073/pnas.242606799.
16. Klein U., Lia M., Crespo M., Siegel R., Shen Q., Mo T., et al. The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Cancer Cell 2010; 17:28-40; PMID:20060366; DOI:10.1016/j.ccr.2009.11.019.
17. Raveche E.S., Salerno E., Scaglione B.J., Manohar V., Abbasi F., Lin Y.C., et al. Abnormal microRNA- 16 locus with synteny to human 13q14 linked to CLL in NZB mice. Blood 2007; 109:5079-86; PMID:17351108; DOI:10.1182/blood-2007- 02- 071225.
18. Oricchio E., Wolfe A.L., Schatz J.H., Mavrakis K.J., Wendel HG. Mouse models of cancer as biological filters for complex genomic data. Dis Model Mech 2010; 3:701-4; PMID:20876355; DOI:10.1242/ dmm.006296.
19. Wendel H.G., De Stanchina E., Fridman J.S., Malina A., Ray S., Kogan S., et al. Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy. Nature 2004; 428:332-7; PMID:15029198; DOI:10.1038/ nature02369.
20. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136:215-33; PMID:19167326; DOI:10.1016/j.cell.2009.01.002.
21. John B., Enright A.J., Aravin A., Tuschl T., Sander C., Marks DS. Human MicroRNA targets. PLoS Biol 2004; 2:363; PMID:15502875; DOI:10.1371/journal. pbio.0020363.
22. Friedman R.C., Farh K.K., Burge C.B., Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009; 19:92-105; PMID:18955434; DOI:10.1101/gr.082701.108.
23. Grimson A., Farh K.K., Johnston W.K., Garrett-Engele P., Lim L.P., Bartel DP. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 2007; 27:91-105; PMID:17612493; DOI:10.1016/j.molcel.2007.06. 017.
24. Lewis B.P., Shih I.H., Jones-Rhoades M.W., Bartel D.P., Burge CB. Prediction of mammalian microRNA targets. Cell 2003; 115:787-98; PMID:14697198; DOI:10.1016/S0092-8674(03)01018-3.
25. Baek D., Villen J., Shin C., Camargo F.D., Gygi S.P., Bartel DP. The impact of microRNAs on protein output. Nature 2008; 455:64-71; PMID:18668037; DOI:10.1038/nature07242.
26. Selbach M., Schwanhausser B., Thierfelder N., Fang Z., Khanin R., Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature 2008; 455:58-63; PMID:18668040; DOI:10.1038/ nature07228.
27. Chi S.W., Zang J.B., Mele A., Darnell R.B. Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature 2009; 460:479-486; PMID:19536157.
28. Mavrakis K.J., Wolfe A.L., Oricchio E., Palomero T., De Keersmaecker K., McJunkin K., et al. Genomewide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia. Nat Cell Biol 2010; 12:372-9; PMID:20190740; DOI:10.1038/ncb2037.
29. Mavrakis K.J., Wendel HG. TargetScreen: An unbiased approach to identify functionally important microRNA targets. Cell Cycle 2010; 9:2080-4; PMID:20505335; DOI:10.4161/cc.9.11.11807.
30. Van Vlierberghe P., Palomero T., Khiabanian H., Van der Meulen J., Castillo M., Van Roy N., et al. PHF6 mutations in T-cell acute lymphoblastic leukemia. Nat Genet 2010; 42:338-42; PMID:20228800; DOI:10.1038/ng.542.
31. Xu Y., Sengupta T., Kukreja L., Minella AC. MicroRNA-223 regulates cyclin E activity by modulating expression of F-box and WD-40 domain protein 7. J Biol Chem 2010; 285:34439-46; PMID:20826802; DOI:10.1074/jbc.M110.152306.
32. Inuzuka H., Shaik S., Onoyama I., Gao D., Tseng A., Maser R.S., et al. SCFFBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction. Nature 2011; 471:104-9; PMID:21368833; DOI:10.1038/nature09732.
33. Wertz I.E., Kusam S., Lam C., Okamoto T., Sandoval W., Anderson D.J., et al. Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7. Nature 2011; 471:110-4; PMID:21368834; DOI:10.1038/nature09779.
34. Huse J.T., Brennan C., Hambardzumyan D., Wee B., Pena J., Rouhanifard S.H., et al. The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes Dev 2009; 23:1327-37; PMID:19487573; DOI:10.1101/ gad.1777409.
35. Kota J., Chivukula R.R., O'Donnell K.A., Wentzel E.A., Montgomery C.L., Hwang H.W., et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 2009; 137:1005-17; PMID:19524505; DOI:10.1016/j.cell.2009.04.021.
36. Medina P.P., Nolde M., Slack FJ. OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 2010; 467:86-90; PMID:20693987; DOI:10.1038/nature09284.
37. Wendel H.G., Malina A., Zhao Z., Zender L., Kogan S.C., Cordon-Cardo C., et al. Determinants of sensitivity and resistance to rapamycin-chemotherapy drug combinations in vivo. Cancer Res 2006; 66:7639-46; PMID:16885364; DOI:10.1158/0008-5472.CAN- 06-0419.
38. Palomero T., Sulis M.L., Cortina M., Real P.J., Barnes K., Ciofani M., et al. Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat Med 2007; 13:1203-10; PMID:17873882; DOI:10.1038/nm1636.
39. Leaman D., Chen P.Y., Fak J., Yalcin A., Pearce M., Unnerstall U., et al. Antisense-mediated depletion reveals essential and specific functions of microRNAs in Drosophila development. Cell 2005; 121:1097-108; PMID:15989958; DOI:10.1016/j. cell.2005.04.016.
40. Miska E.A., Alvarez-Saavedra E., Abbott A.L., Lau N.C., Hellman A.B., McGonagle S.M., et al. Most Caenorhabditis elegans microRNAs are individually not essential for development or viability. PLoS Genet 2007; 3:215; PMID:18085825; DOI:10.1371/journal. pgen.0030215.
41. O'Donnell K.A., Wentzel E.A., Zeller K.I., Dang C.V., Mendell JT. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 2005; 435:839-43; PMID:15944709; DOI:10.1038/nature03677.